{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T07:07:28Z","timestamp":1656054448170},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,2,6]],"date-time":"2009-02-06T00:00:00Z","timestamp":1233878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00120-008-1918-8","type":"journal-article","created":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T18:51:58Z","timestamp":1233773518000},"page":"233-244","source":"Crossref","is-referenced-by-count":4,"title":["Botulinumtoxin bei nichtneurogenen Blasenfunktionsst\u00f6rungen"],"prefix":"10.1007","volume":"48","author":[{"given":"U.","family":"Mehnert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schurch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,6]]},"reference":[{"key":"1918_CR1","first-page":"5","volume":"175","author":"Wein","year":"2006","unstructured":"Wein AJ, Rackley RR (2006) Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 175: 5\u201310","journal-title":"J Urol"},{"key":"1918_CR2","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50: 1306\u20131315","journal-title":"Eur Urol"},{"key":"1918_CR3","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.eururo.2006.11.040","volume":"51","author":"Klotz","year":"2007","unstructured":"Klotz T, Bruggenjurgen B, Burkart M et al (2007) The economic costs of overactive bladder in Germany. Eur Urol 51: 1654\u20131663","journal-title":"Eur Urol"},{"key":"1918_CR4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.eururo.2008.01.027","volume":"53","author":"Irwin","year":"2008","unstructured":"Irwin DE, Milsom I, Kopp Z et al (2008) Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol 53: 1029\u20131037","journal-title":"Eur Urol"},{"key":"1918_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-5347(05)00067-4","volume":"175","author":"Hashim","year":"2006","unstructured":"Hashim H, Abrams P (2006) Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 175: 191\u2013195","journal-title":"J Urol"},{"key":"1918_CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"Karsenty","year":"2008","unstructured":"Karsenty G, Denys P, Amarenco G et al (2008) Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur Urol 53: 275\u2013287","journal-title":"Eur Urol"},{"key":"1918_CR7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"Apostolidis","year":"2005","unstructured":"Apostolidis A, Popat R, Yiangou Y et al (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174: 977\u2013983","journal-title":"J Urol"},{"key":"1918_CR8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.urology.2005.01.055","volume":"66","author":"Khera","year":"2005","unstructured":"Khera M, Somogyi GT, Salas NA et al (2005) In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology 66: 208\u2013212","journal-title":"Urology"},{"key":"1918_CR9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/nau.20403","volume":"26","author":"Ghalayini","year":"2007","unstructured":"Ghalayini IF, Al-Ghazo MA (2007) Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: urodynamic outcome and patient satisfaction. Neurourol Urodyn 26: 531\u2013536","journal-title":"Neurourol Urodyn"},{"key":"1918_CR10","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","volume":"174","author":"Ghei","year":"2005","unstructured":"Ghei M, Maraj BH, Miller R et al (2005) Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J Urol 174: 1873\u20131877","journal-title":"J Urol"},{"key":"1918_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.urology.2006.09.005","volume":"69","author":"Hirst","year":"2007","unstructured":"Hirst GR, Watkins AJ, Guerrero K et al (2007) Botulinum toxin B is not an effective treatment of refractory overactive bladder. Urology 69: 69\u201373","journal-title":"Urology"},{"key":"1918_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2007.12.029","volume":"54","author":"Kalsi","year":"2008","unstructured":"Kalsi V, Apostolidis A, Gonzales G et al (2008) Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity. Eur Urol 54: 181\u2013187","journal-title":"Eur Urol"},{"key":"1918_CR13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","volume":"49","author":"Kalsi","year":"2006","unstructured":"Kalsi V, Apostolidis A, Popat R et al (2006) Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 49: 528\u2013535","journal-title":"Eur Urol"},{"key":"1918_CR14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","volume":"49","author":"Kalsi","year":"2006","unstructured":"Kalsi V, Popat RB, Apostolidis A et al (2006) Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. Eur Urol 49: 519\u2013527","journal-title":"Eur Urol"},{"key":"1918_CR15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","volume":"24","author":"Kessler","year":"2005","unstructured":"Kessler TM, Danuser H, Schumacher M et al (2005) Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 24: 231\u2013236","journal-title":"Neurourol Urodyn"},{"key":"1918_CR16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","volume":"63","author":"Kuo","year":"2004","unstructured":"Kuo HC (2004) Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 63: 868\u2013872","journal-title":"Urology"},{"key":"1918_CR17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.urology.2006.05.054","volume":"68","author":"Kuo","year":"2006","unstructured":"Kuo HC (2006) Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity? Urology 68: 993\u2013998","journal-title":"Urology"},{"key":"1918_CR18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"Popat","year":"2005","unstructured":"Popat R, Apostolidis A, Kalsi V et al (2005) A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174: 984\u2013989","journal-title":"J Urol"},{"key":"1918_CR19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","volume":"63","author":"Rapp","year":"2004","unstructured":"Rapp DE, Lucioni A, Katz EE et al (2004) Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 63: 1071\u20131075","journal-title":"Urology"},{"key":"1918_CR20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","volume":"65","author":"Smith","year":"2005","unstructured":"Smith CP, Nishiguchi J, O\u2019Leary M et al (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65: 37\u201341","journal-title":"Urology"},{"key":"1918_CR21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00192-003-1099-3","volume":"14","author":"Dykstra","year":"2003","unstructured":"Dykstra D, Enriquez A, Valley M (2003) Treatment of overactive bladder with botulinum toxin type B: a pilot study. Int Urogynecol J Pelvic Floor Dysfunct 14: 424\u2013426","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"1918_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","volume":"180","author":"Brubaker","year":"2008","unstructured":"Brubaker L, Richter HE, Visco A et al (2008) Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 180: 217\u2013222","journal-title":"J Urol"},{"key":"1918_CR23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","volume":"177","author":"Sahai","year":"2007","unstructured":"Sahai A, Khan MS, Dasgupta P (2007) Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 177: 2231\u20132236","journal-title":"J Urol"},{"key":"1918_CR24","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.ju.0000143889.00681.3f","volume":"172","author":"Flynn","year":"2004","unstructured":"Flynn MK, Webster GD, Amundsen CL (2004) The effect of botulinum-A toxin on patients with severe urge urinary incontinence. J Urol 172: 2316\u20132320","journal-title":"J Urol"},{"key":"1918_CR25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1464-410X.2007.07186.x","volume":"100","author":"Jeffery","year":"2007","unstructured":"Jeffery S, Fynes M, Lee F et al (2007) Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int 100: 1302\u20131306","journal-title":"BJU Int"},{"key":"1918_CR26","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2006.10.047","volume":"177","author":"Karsenty","year":"2007","unstructured":"Karsenty G, Elzayat E, Delapparent T et al (2007) Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. J Urol 177: 1011\u20131014","journal-title":"J Urol"},{"key":"1918_CR27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","volume":"66","author":"Kuo","year":"2005","unstructured":"Kuo HC (2005) Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics. Urology 66: 94\u201398","journal-title":"Urology"},{"key":"1918_CR28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","volume":"178","author":"Kuo","year":"2007","unstructured":"Kuo HC (2007) Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. J Urol 178: 1359\u20131363","journal-title":"J Urol"},{"key":"1918_CR29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1464-410X.2005.05725.x","volume":"96","author":"Rajkumar","year":"2005","unstructured":"Rajkumar GN, Small DR, Mustafa AW et al (2005) A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 96: 848\u2013852","journal-title":"BJU Int"},{"key":"1918_CR30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","volume":"176","author":"Schmid","year":"2006","unstructured":"Schmid DM, Sauermann P, Werner M et al (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176: 177\u2013185","journal-title":"J Urol"},{"key":"1918_CR31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2005.06.021","volume":"48","author":"Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Weiss C, Stolze T et al (2005) Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol 48: 984\u2013990","journal-title":"Eur Urol"},{"key":"1918_CR32","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","volume":"192","author":"Werner","year":"2005","unstructured":"Werner M, Schmid DM, Schussler B (2005) Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am J Obstet Gynecol 192: 1735\u20131740","journal-title":"Am J Obstet Gynecol"},{"key":"1918_CR33","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","volume":"68","author":"Karsenty","year":"2006","unstructured":"Karsenty G, Reitz A, Lindemann G et al (2006) Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urology 68: 1193\u20131197","journal-title":"Urology"},{"key":"1918_CR34","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","volume":"52","author":"Reitz","year":"2007","unstructured":"Reitz A, Denys P, Fermanian C et al (2007) Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur Urol 52: 1729\u20131735","journal-title":"Eur Urol"},{"key":"1918_CR35","first-page":"39","volume":"177","author":"Gousse","year":"2007","unstructured":"Gousse A, Cohen B, Rodriguez D et al (2007) Scheduled repeated Botox injections for idiopathic OAB: evaluating therapeutic time. J Urol 177: 39","journal-title":"J Urol"},{"key":"1918_CR36","doi-asserted-by":"crossref","unstructured":"Cohen BL, Barboglio P, Rodriguez D et al (2008) Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units. Neurourol Urodyn (Epub ahead of print)","DOI":"10.1002\/nau.20611"},{"key":"1918_CR37","first-page":"3291","volume":"13","author":"Lucioni","year":"2006","unstructured":"Lucioni A, Rapp DE, Gong EM et al (2006) Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection. Can J Urol 13: 3291\u20133295","journal-title":"Can J Urol"},{"key":"1918_CR38","first-page":"547","volume":"24","author":"Karsenty","year":"2005","unstructured":"Karsenty G, Boy S, Reitz A et al (2005) Botulinum toxin A (BTA) in the treatment of neurogenic detrusor overactivity incontinence. A prospective randomized study to compare 30 vs. 10 injection sites. Neurourol Urodyn 24: 547","journal-title":"Neurourol Urodyn"},{"key":"1918_CR39","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/end.2005.19.880","volume":"19","author":"Smith","year":"2005","unstructured":"Smith CP, Chancellor MB (2005) Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection. J Endourol 19: 880\u2013882","journal-title":"J Endourol"},{"key":"1918_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-1331.2006.01439.x","volume":"13","author":"Dressler","year":"2006","unstructured":"Dressler D, Hallett M (2006) Immunological aspects of Botox, Dysport and Myobloc\/NeuroBloc. Eur J Neurol 13(Suppl 1): 11\u201315","journal-title":"Eur J Neurol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1918-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-008-1918-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1918-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:58:54Z","timestamp":1558594734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-008-1918-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["1918"],"URL":"https:\/\/doi.org\/10.1007\/s00120-008-1918-8","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,6]]}}}